A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment
Clinical trial NCT05374343 · COMPLETED
Trial details
- NCT number
- NCT05374343
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2023-08-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.